Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chiang Mai Ram Medical Business Public Company Limited (CMR.BK)
Chiang Mai, TH
Chiang Mai Ram Medical Business Public Company Limited is a Thai healthcare provider primarily operating medical facilities. The company delivers a comprehensive array of medical services, encompassing core specializations such as internal medicine, cardiology, general practice, pediatrics, orthopedics, various surgical fields (general and pediatric), obstetrics-gynecology, radiology, dentistry, anesthesiology, otolaryngology (ENT), and ophthalmology. Beyond these fundamental areas, CMR.BK manages specialized clinics for conditions like urological, neurological, endocrine, oncological, hematological, plastic surgery, gastrointestinal, and dermatological issues, alongside dedicated clinics for infertility and gynecologic oncology. The company further extends its offerings to include a variety of diagnostic and therapeutic services such as dental care, advanced imaging (X-ray, CT colonoscopy), cardiac catheterization, gynecologic cancer treatments, back pain management, physical therapy and rehabilitation, surgical operating theatres, laboratory examinations (including real-time PCR), ambulance services, CRD, and comprehensive health check-ups. Additionally, it provides insurance products. CMR.BK operates its primary medical care center under the name Lanna Hospital. Established in 1974, the company's headquarters are located in Chiang Mai, Thailand. It functions as a subsidiary of Vibhavadi Medical Center Public Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.77% | +1.55% | -6.43% | -3.68% | -7.75% | +10.08% | -47.18% | -44.02% | -67.57% | +298.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-52.8% Q1'26: -54.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+1,769.2% ★ Q1'26: -33.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-2.0% Q1'26: +2.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+3.7% Q1'26: +8.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+1.4% Q1'26: +2.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×4.13× Q1'26: 4.39× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dusit Srisakul | MD, Hospital Director & Executive Director | — | — |
| Sumeth Handagoon | Executive Director | — | — |
| Teerayut Niyomkul | Hospital Director & Executive Director | — | — |
| Thawatchai Tansathit | Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CMR.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
